Literature DB >> 11016587

Inhibitory effects of morphine on some inflammation-related parameters in the goldfish Carassius auratus L.

M Chadzinska1, A Scislowska-Czarnecka, B Plytycz.   

Abstract

Acute peritonitis induced in the goldfish by intraperitoneal injection of a sterile Thioglycollate solution shows a typical pattern with intraperitoneal exudation of serum proteins followed by influx of leucocytes (mainly heterophils/macrophages) correlated with elevated levels of chemotactic factors in peritoneal fluid and blood plasma. Supplementation of Thioglycollate with morphine (20 mg kg(-1) b.w.) does not affect the leakage of serum proteins into peritoneum. In contrast, it reduces the number of exudate peritoneal leucocytes (among them heterophils/macrophages) to the control level and decreases the level of peritoneal fluid/plasma chemoattractants, both effects being reversed by naltrexone pretreatment. Morphine itself acts as a chemokinetic factor for fish leucocytes as it increases their random movements. Therefore inhibitory effects of morphine on accumulation of exudate cells might be explained by inhibition of the production/release of chemotactic factors and/or reduced sensitivity of leucocytes to chemotactic signals. The effects of morphine on the goldfish peritonitis are in concordance with those described recently in Atlantic salmon and CB6 mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016587     DOI: 10.1006/fsim.2000.0270

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  2 in total

1.  Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA mice.

Authors:  Elzbieta Stankiewicz; Ewa Wypasek; Barbara Plytycz
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

2.  Met-enkephalin involvement in morphine-modulated peritonitis in swiss mice.

Authors:  Magdalena Chadzinska; Anna Scislowska-Czarnecka; Krystyna Pierzchala-Koziec; Barbara Plytycz
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.